Comparison the effect of two days interval amikacin with standard therapy in treatment of urinary tract infectio
Phase 3
Recruiting
- Conditions
- TI.Urinary tract infection, site not specified
- Registration Number
- IRCT20170417033483N2
- Lead Sponsor
- Kurdistan university of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Patients with symptoms of burning up urine
Patients with frequent urinary symptoms
Patients with urinary symptoms and fever
Exclusion Criteria
Use of antibiotics over the last week
Stage I and above CKD
pregnancy
septic shock
use of immuno suppressive drugs
Increased patient creatinine by more than 3 or more than 50% relative to the original creatinine during treatment
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rinary tract infection(UTI). Timepoint: 7 days after the start of treatment, intravenous and oral treatment phase (7 days. Method of measurement: Urine analysis and urina culture.;Clinical symptoms of UTI. Timepoint: 48 hours and 1 week after the end of therapy with intravenous and oral treatment. Method of measurement: By patient symptoms and clinical findings.
- Secondary Outcome Measures
Name Time Method Adverse Drug Reactions. Timepoint: 48 hours and 1 week after treatment and at the end of intravenous and oral treatment. Method of measurement: Clinical symptoms and examination findings, laboratory.